Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer

Nicolai Maass, Marco Biallek, Frank Rösel, Christian Schem, Nobuyuki Ohike, Ming Zhang, Walter Jonat, Koichi Nagasaki*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Maspin is a member of the serine protease inhibitor family with tumor suppressing activity in breast cancer. Maspin expression was found in normal breast epithelial cells, but was frequently decreased in breast cancer cells and lost in metastatic cells. In this study, we examined the regulatory mechanism of maspin expression and described the re-activation of maspin expression in a series of maspin-negative breast cancer cell lines. All of the 6 maspin-negative breast cancer cells showed induction of maspin promoter activity in a promoter reporter assay. In addition, the treatment of 5-aza-2′ deoxycytidine, trichostatin A or a combination of both led to the re-expression of maspin in a series of maspin-negative breast cancer cell lines. These findings indicate that DNA methylation and/or histone deacetylation are/is partially responsible for the silencing of maspin gene expression in breast cancer cells. The re-expression of maspin by pharmacological intervention potentially o6ers a promising new target as a therapeutic option in breast cancer.

Original languageEnglish (US)
Pages (from-to)125-128
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume297
Issue number1
DOIs
StatePublished - 2002

Keywords

  • 5-AZA-dC
  • Breast cancer
  • DNA methylation
  • Histone deacetylation
  • Maspin
  • TSA

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer'. Together they form a unique fingerprint.

Cite this